FDA Clearance Tracker · K202989
Myopia Master
Last checked: Nov 19, 2026Latest source record: Jul 14, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Jul 14, 2021
Substantially Equivalent
Time to decision
287 days
Received Sep 30, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K202989
- Device name
- Myopia Master
- Applicant
- Oculus Optikgeräte GmbH
- Applicant location
- Wetzlar, DE
- Received
- Sep 30, 2020
- Decided
- Jul 14, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Device, Analysis, Anterior Segment (MXK)
- Device class
- Class II
- Regulation
- 21 CFR 886.1850
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MXK. The earliest in FDA's data is K984443, decided Mar 5, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K202989
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Oculus Optikgeräte GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.